Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
Clinical trial NCT03139370 · TERMINATED
Trial details
- NCT number
- NCT03139370
- Sponsor
- Kite, A Gilead Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-27
- Primary completion
- 2021-06-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.